WTC
HAE icon

WhitTier Trust Company’s Haemonetics HAE Stock Holding History

WhitTier Trust Company’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12K Buy
55
+10
+22% +$642 ﹤0.01% 1197
2026
Q1 		$2.63K Buy
+45
New +$2.93K ﹤0.01% 1237
2013
Q3 		– Sell
-362
Closed -$15K – 874
2013
Q2 		$15K Buy
+362
New +$14.7K ﹤0.01% 696

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WhitTier Trust Company's HAE Position: Q2 2026 in Review

WhitTier Trust Company increased its Haemonetics (HAE) stake by 22% in Q2 2026, buying an estimated $642 and bringing the position to 55 shares worth $4.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

WhitTier Trust Company first reported a position in HAE in Q2 2013 and has held it in 3 quarters since. The position peaked at $15K in Q2 2013. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • WhitTier Trust Company held 55 shares of Haemonetics worth $4.12K as of Q2 2026.
  • WhitTier Trust Company bought 10 Haemonetics shares in Q2 2026, an estimated $642.
  • Haemonetics made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1197 holding.
  • WhitTier Trust Company first reported a position in Haemonetics in Q2 2013 and has held it in 3 quarters since.
  • WhitTier Trust Company's Haemonetics position peaked at $15K in Q2 2013.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.